PVSRIPO and Pembrolizumab in Patients With Recurrent Glioblastoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 10
Summary
- Conditions
- Brain Tumor
- Glioblastoma
- Recurrent Glioblastoma
- Supratentorial Glioblastoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04479241
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon